Professionals 227 Users Online

Microfluidic Devices Market

Rising prevalence of chronic diseases, as well as advancements in point-of-care diagnostics, are set to propel the overall microfluidic devices market

Microfluidic Devices Market Segmented By Glass, Polymer, Silicon Material in In-vitro diagnostics, Pharmaceutical, Medical Devices for Point of care testing, Drug Delivery, Analytical devices, Clinical and veterinary diagnostics, Environment and Industrial

Microfluidic Devices Market Outlook (2023-2033)

The global revenue from the microfluidic devices market stands at US$ 6.9 Bn in 2022, with the global market expected to grow at a CAGR of 10.2% to reach a valuation of approximately US$ 20.9 Bn by the end of 2033.

Market Size (2022)

US$ 6.9 Bn

Projected Market Value (2033)

US$ 20.9 Bn

Global Market Growth Rate (2023-2033)

10.2% CAGR

Market Share of Top 5 Countries


As assessed by Persistence Market Research, ceramic materials are expected to hold a market value of around US$ 9.9 Bn by 2033. Overall, microfluidic devices market sales account for approximately 34.2% revenue share in the global microfluidics market, which was valued at around US$ 20.14 Bn in 2022.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Sales Analysis of Microfluidic Devices Market from 2014 to 2022 Vs Market Outlook for 2023 to 2033

The global market recorded a historic CAGR of 14.0% in the last 8 years from 2014 to 2022.

The principles of fluid dynamics, microelectronics, physics, chemistry, biology, and material science are integrated to provide the foundation of the rapidly developing field of microfluidics. Different materials can be manufactured into micro chips with microscale channels and chambers. Such platforms can be produced using a variety of techniques to get the desired size and shape, shape, and geometry.

Microfluidic chips can be used in cell analysis, diagnosis, and culture, as well as in the preparation of nanoparticles, drug encapsulating, delivery, and targeting.

Globally, there is an epidemic of the human immunodeficiency virus (HIV), yet many patients may get treatment and take care of their condition. Late-stage HIV infection leads to the development of acquired immunodeficiency syndrome (AIDS), which weakens the immune system and leaves it vulnerable to infections.

Although there is no cure, antiretroviral treatment can be administered if detection occurs, preferably in the initial stages. When testing for HIV using conventional techniques like flow cytometry, PCR, or ELISA, the cost and resource requirements are high.

Equipment that is economical, portable, and capable of producing rapid results is required to enhance disease diagnosis in resource-constrained settings. Many benchtop techniques have been transformed into on-chip detection enabling portable and rapid point-of-care (POC) diagnostics owing to microfluidic devices. These tools can be utilised in locations with limited resources since they are sensitive, rapid, and cost-effective.

Additionally, they can compete in functionality with their benchtop equivalents, making them effective for disease diagnosis. Viral load testing is expensive and needs a complex lab infrastructure, both of which may not be easily available in settings with limited resources.

This necessitates the development of more portable, sensitive, and efficient microdevices that can assure testing accessibility. Technology advancements have enabled the development of handheld devices, microfluidics, lensless smartphone imaging, and multiplexing.

Owed to the cost-effectiveness, portability, and accuracy of results in disease diagnostics, the global market is likely to show high growth over the coming years at a CAGR of 10.2% and reach a global market size of US$ 20.9 Bn by 2033.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

How Can the Global Microfluidic Devices Market Grow?

Applications of microfluidics for enhanced procedural outcome

In particular, bioscience, biomedical, and biotechnological research have benefited greatly from the use of microfluidic technology in a wide range of applications. It has recently increased the effectiveness of molecular research and enabled notable advancement in a number of bioresearch domains.

Microfluidic technology allows for exact volume manipulation of samples outside of cellular environments. As a result, it will eventually be conceivable to diminish disparities between in vivo and in vitro settings and drastically cut on both the time required for reaction rates and overall cost.

To better comprehend in vivo conditions, microfluidic techniques have made significant advancements. Micro-arrays in general and cell-based microarrays in particular, when combined with other cutting-edge technologies like optical and electrical detection techniques and a well-designed microfluidic system, have proven beneficial for tracking changes in cellular behaviour as a result of environmental influences.

Additionally, the cell-based micro-arrays can aid in the correct adhesion or development of numerous cell types on various substrates. The development of innovative arrays has so far involved a number of concepts, including suspension arrays, also known as high-throughput cell-based assays, and positional arrays, also known as multiplexed cell-based arrays.

Numerous novel innovations, including lab-on-a-chip and organs-on-a-chip, are being made to advance the state-of-the-art microfluidic technologies. The projects for organs-on-a-chip and labs-on-a-chip are anticipated to continue being the focus of intensive research in a variety of fields of research and material-based sectors.

To sum up, the application of advanced technologies to the development of microfluidic devices would not only increase output but also provide an accessible platform for various bio-applications, thus propelling the overall value of the global market.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Can the Microfluidic Devices Market Growth Be Affected in Any Way?

Limitations associated with material costs

The limitations of traditional monolithic microfluidic chips become increasingly apparent as microfluidic applications expand. A major obstacle to the expansion of the microfluidics industry has been the high cost of research and development for products based on the technology and the lack of financial assistance.

Lengthy development periods for projects of research and development coupled with the cost of the clinical trials required to assess the devices and chips add to a significant cost. Due to this, manufacturers must exercise caution and ensure that their investments are made in markets that will yield higher returns.

The high development costs of microfluidics chips and devices come with risks and limitations that could impede the growth of the global market.

Additionally, silicon and glass are used in the fabrication of the microfluidics systems, which is performed in a clean room. Due to its transparency to visible and ultraviolet light, silicon is a material that cannot be used with microscopic technologies. Both glass and silicon have challenging bonding procedures for closing microchannels, making them both brittle materials.

Additionally, they call for labor-intensive and expensive fabrication techniques, which is anticipated to restrain market expansion throughout the projection period.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Country-wise Insights

Why is the U.S. Microfluidic Devices Market Booming?

“Rising applications of microfluidics and presence of a developed healthcare system”

The U.S. accounted for around 64.0% market share in the North America market in 2022. Chronic disease prevalence is increasing, which is driving up demand for skin grafting procedures. Another reason driving the market growth rate is the increased demand for point-of-care testing equipment along with the growing number of technological advancements in POC devices.

Growing medical tourism, increasing attention on data quality and accuracy, increasing spending on the development of healthcare infrastructure, especially in emerging nations, and an ever-increasing geriatric population base will all lead to more attractive growth prospects for the industry.

Will U.K. Be a Lucrative Market for Microfluidic Devices?

“Presence of associations for advancement in microfluidic technology”

U.K. held around 3.7% market share of the global market in 2022. The market within the country is expanding as a result of rapid adoption of microfluidics in the U.K. Several associations within the region are associated with working towards the development of microfluidics, such as the European Federation of National Engineering Associations, and the European Association for Fluid Dynamics.

Moreover, with growing awareness on point-of-care diagnostics, as well as the rising burden of chronic disease owed to lifestyle habits, as well as the presence of a large population of smokers, have further propelled microfluidics applications within the country.

How is China Emerging as a Prominent Market?

“Government support for emerging Chinese players within the market”

China held a market share of about 5.5% of the global market in 2022. The Chinese government has developed a strategic plan to completely modernise the nation's industrial sector and make China a significant player that is independent from other nations. The "Made in China 2025" plan places an emphasis on pharmaceuticals and medical equipment. This enormous investment will undoubtedly be beneficial to microfluidic technology, which is a crucial tool for diagnostics as well as life sciences applications.

In addition, while multinational corporations like Roche and Abbott presently control the Chinese diagnostics market, new Chinese businesses are emerging to challenge them. The existing dominance of international players leads in products that are considered overly expensive and often far beyond reimbursement thresholds, which presents a major opportunity for these emerging Chinese players.

Category-wise Insights

Which Material is Driving Demand within the Global Microfluidic Devices Market?

“Greater durability and higher temperature resistance”

The ceramic segment held the largest share in the global market in 2022 and are expected to hold a market value of around US$ 9.9 Bn by 2033. In contrast to Si and glass platforms, ceramic microfluidic platforms can be made utilising lower temperature co-fired ceramics technology, resulting in tightly sealed monolithic microfluidic systems with homogenous surface properties and physical properties of the material.

These offer far greater strength and chemical resistance than silicon or plastic, as well as higher strength than glass and high temperature stability.

Which Application for Microfluidic Devices is Largely of Focus within the Global Market?

“Advantages of early disease diagnostics”

Point of care testing held a share of about 32.6% in 2022 globally. Rapid disease detection is possible with low-cost microfluidic point-of-care (POC) devices. By early disease detection, it is possible to minimize its impact and raise living standards in undeveloped regions.

These POC devices, which are based on microfluidics, have tremendous potential to enhance healthcare, including simple monitoring, disease early detection, and greater personalization.

Which Industry Provides the Global Market With a Large Share?

“Applications of microfluidics in drug discovery and screening”

The in-vitro diagnostics industry held a share of about 31.6% in 2022 within the global market. Numerous benefits, including mobility, affordability, automation, and "sample-to-answer" capability, are thought to be available with microfluidic in-vitro diagnostic devices. These capabilities could enable quick, sensitive, and quantitative investigations of several targets while using relatively few samples.

In addition, engineered microfluidics in in vitro cell culture models are developing as potential methods to understand human development, progression of the disease, and deliver reliable, efficient, and economical outcomes for drug discovery and screening. These factors propel the in-vitro diagnostics segment within the global market.

Competition Landscape

The global microfluidics market is mostly focused on consolidation. Merger and acquisition activities, strategic collaborations, and patent transfer agreements are all important in the microfluidics business.

Because quality and successful outcomes are critical to the end use industry, it is essential to efficiently address the needs of diverse end users in a variety of applications while ensuring product supply.

Some key instances of development include:

  • The commercial launch of Horizon Microtechnologies' template-based 3D microfabrication technology, which manufactures conductive micro additive manufacturing derived parts with micrometer-scale accuracy, took place in Frankfurt, Germany, in November 2022.
  • Thermo Fisher Scientific Inc. acquired the developer of the PAC line of micro-chip-based chromatography columns, PharmaFluidics, based in Belgium, in November 2021.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the microfluidic devices market, which are available in the full report.

Microfluidic Devices Industry Report Scope



Forecast Period


Historical Data Available for


Market Analysis

USD Million for Value

Key Countries Covered

  • U.S.
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Russia
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Turkey
  • GCC
  • North Africa
  • South Africa

Key Market Segments Covered

  • Material
  • Application
  • Industry
  • Region

Key Companies Covered

  • Agilent Technologies
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen NV
  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Horizon Microtechnologies

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments Covered in Global Microfluidic Devices Industry Research


  • Polymer
    • Polyvinyl Chloride (PVC)
    • Non-polyvinyl Chloride
  • Glass
  • Silicon
  • Metal
  • Ceramics


  • Point of care testing
  • Clinical Diagnostics
  • Drug Delivery
  • Analytical Testing
    • Genomics
    • Proteomics
    • Cell based Analysis
    • Others


  • Pharmaceuticals
  • In-vitro Diagnostics
  • Environmental Research
  • Life Science Research
  • Clinical Diagnostics


  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

- Companies Covered in This Report -

  • Agilent Technologies
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen NV
  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Horizon Microtechnologies

- Frequently Asked Questions -

The global market is currently valued at around US$ 6.9 Bn in 2022.

Sales of the market are set to witness growth at a CAGR of 10.2% and be valued at around US$ 20.9 Bn by 2033.

Demand for the global market increased at a 14.0% CAGR from 2014 to 2022.

The U.S., Japan, Canada, China, and Russia account for most demand within the market, currently holding around 46.8% market share.

The U.S. accounts for around 64.0% share of the North American market in 2022.

Latin America accounts for around 9.3% share of the global market in 2022.

China held a market share of about 5.5% of the global market in 2022

U.K. held around 3.7% market share of the global market in 2022.

The Brazil market is expected to grow at an 8.8% CAGR during the forecast period.

The market in India is set to expand at an 11.6% CAGR over the forecast period.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate